MAPT and frontotemporal dementia: In conclusion, the diverse mutations within the MAPT gene associated with disease reveal a complex genetic basis for MAPT-related FTD, with some mutations potentially leading to a loss of TAU’s canonical MT-binding function, and others causing a toxic GoF, both resulting in TAU filament assembly.